ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1512

Epigenetic and Transcriptional Programs of CD4+ T Cell Anergy

Philip Titcombe, Milagros Silva Morales and Daniel Mueller, University of Minnesota, Minneapolis, MN

Meeting: ACR Convergence 2021

Keywords: genomics, immunology, T Cell, transcription factor, Treg cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 9, 2021

Title: T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster (1507–1515)

Session Type: Poster Session D

Session Time: 8:30AM-10:30AM

Background/Purpose: T cell tolerance is essential for preventing autoimmune diseases and resolving inflammation. To maintain tolerance, CD4+ T cells recognizing self-antigens in the periphery can exert active suppression as regulatory T cells (Treg) or enter an inactive state known as anergy. Recent evidence suggests that anergy occurs naturally within a subpopulation of polyclonal CD4+ T cells and can generate precursors to Foxp3-expressing Treg cells. We aimed to identify transcription factors (TFs) underlying T cell anergy induction and its potential plasticity.

Methods: Polyclonal CD4+ T cell subsets from untreated C57BL/6 mice were sorted based on previously established markers for downstream sequencing-based interrogation. Anergic CD44high Foxp3– CD73high FR4high Nrp1+ T cells were compared to effector-memory (CD44high Foxp3– CD73low FR4low), Treg (Foxp3+ CD25+), and naïve (CD44low) T cell populations. Divided aliquots from the same samples were processed in parallel to generate corresponding bulk RNA-seq and accessible chromatin DNA information. Bioinformatic analyses were applied to identify unique transcriptional networks in the anergic T cell subpopulation. Anergy-enriched TFs were then investigated in an antigen-specific system of tolerization by repeated peptide infusions.

Results: Paired epigenome and transcriptome analysis revealed a unique anergy signature driven by bZIP family (Batf, Cebpa, Nfil3, Maf), NFAT family (Nfatc1), and EGR family (Egr3) transcription factors. In response to peptide tolerization, antigen-specific CD4+ T cells from Batf-deficient mice demonstrated exaggerated expansion and minimal Foxp3+ Treg cell differentiation.

Conclusion: Our data indicate that a unique transcription factor network, including BATF, generates and maintains peripheral CD4+ T cell anergy.

Anergic T cells exhibit a distinct transcriptional program.


Disclosures: P. Titcombe, None; M. Silva Morales, None; D. Mueller, None.

To cite this abstract in AMA style:

Titcombe P, Silva Morales M, Mueller D. Epigenetic and Transcriptional Programs of CD4+ T Cell Anergy [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/epigenetic-and-transcriptional-programs-of-cd4-t-cell-anergy/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/epigenetic-and-transcriptional-programs-of-cd4-t-cell-anergy/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology